136 related articles for article (PubMed ID: 36763919)
1. Effect of topical oxytocin gel on vaginal mucosa in postmenopausal Egyptian women: a clinical randomized trial.
Moussa A; Moberg KU; Elgrahy I; Elsayied M; Abdel-Rasheed M; Farouk M; Saad H; Meshaal H
J Sex Med; 2023 Feb; 20(2):177-183. PubMed ID: 36763919
[TBL] [Abstract][Full Text] [Related]
2. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
[TBL] [Abstract][Full Text] [Related]
3. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
Jonasson AF; Edwall L; Uvnäs-Moberg K
Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
[TBL] [Abstract][Full Text] [Related]
4. Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial.
Torky HA; Taha A; Marie H; El-Desouky E; Raslan O; Moussa AA; Ahmad AM; Abo-Louz A; Zaki S; Fares T; Eesa A
Climacteric; 2018 Apr; 21(2):174-178. PubMed ID: 29347848
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
[TBL] [Abstract][Full Text] [Related]
6. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Oxytocin Vaginal Gel on Sexual Function in Postmenopausal Women: A Randomized Controlled Trial.
Abedi P; Zohrabi I; Ansari S; Maraghi E; Maram NS; Houshmand G
J Sex Marital Ther; 2020; 46(4):377-384. PubMed ID: 32169019
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
[TBL] [Abstract][Full Text] [Related]
9. Effect of estradiol vaginal gel on vaginal atrophy in postmenopausal women: A randomized double-blind controlled trial.
Tanmahasamut P; Jirasawas T; Laiwejpithaya S; Areeswate C; Dangrat C; Silprasit K
J Obstet Gynaecol Res; 2020 Aug; 46(8):1425-1435. PubMed ID: 32715556
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
[TBL] [Abstract][Full Text] [Related]
11. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
[TBL] [Abstract][Full Text] [Related]
13. Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.
Simon JA; Archer DF; Kagan R; Bernick B; Graham S; Constantine GD; Mirkin S
Menopause; 2017 Sep; 24(9):1003-1010. PubMed ID: 28419068
[TBL] [Abstract][Full Text] [Related]
14. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.
Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO
Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393
[TBL] [Abstract][Full Text] [Related]
16. TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.
Kingsberg SA; Derogatis L; Simon JA; Constantine GD; Graham S; Bernick B; Gasper G; Mirkin S
J Sex Med; 2016 Dec; 13(12):1930-1937. PubMed ID: 27692842
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of oxytocin gel in postmenopausal women with vaginal atrophy: an updated systematic review and meta-analysis.
Farahat RA; Salamah HM; Mahmoud A; Hamouda E; Hashemy M; Hamouda H; Samir A; Chenfouh I; Marey A; Awad DM; Farag E; Abd-Elgawad M; Eldesouky E
BMC Womens Health; 2023 Sep; 23(1):494. PubMed ID: 37716966
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
